Thaddeus J. Edens
Thaddeus J. Edens has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Amee R. Manges
British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
2 shared publications - Caroline Vincent
Department of Microbiology and Immunology, McGill University, Montréal, Québec, Canada
2 shared publications - Ken Dewar
Department of Human Genetics, McGill University, Montreal, QC H3A 1Y2, Canada
2 shared publications - David A. Stephens
Department of Mathematics and Statistics, McGill University , H3A 0B9,Montreal
1 shared publication - Marcel A. Behr
Department of Microbiology and Immunology, McGill University, Montreal, Canada
1 shared publication - Mark A. Miller
Jewish General Hospital, Montreal, Quebec, Canada
1 shared publication
Latest Publications
- Open Access
- 14 March 2016
- Published by Springer Nature in Microbiome
- Vol. 4 (1) , 1-11
Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection
Clostridium difficile infection (CDI) is the leading infectious cause of nosocomial diarrhea. Hospitalized patients are at increased risk of developing CDI because they are exposed to C. difficile spores through contact with the hospital environment and often receive antibiotics and other medications that can disrupt the integrity of the indigenous intestinal microbiota and impair colonization resistance. Using whole metagenome shotgun sequencing, we examined the diversity and composition of the fecal microbiota in a prospective cohort study of 98 hospitalized patients. Four patients had asymptomatic C. difficile colonization, and four patients developed CDI. We observed dramatic shifts in the structure of the gut microbiota during hospitalization. In contrast to CDI cases, asymptomatic patients exhibited elevated relative abundance of potentially protective bacterial taxa in their gut at the onset of C. difficile colonization. Use of laxatives was associated with significant reductions in the relative abundance of Clostridium and Eubacterium; species within these genera have previously been shown to enhance resistance to CDI via the production of secondary bile acids. Cephalosporin and fluoroquinolone exposure decreased the frequency of Clostridiales Family XI Incertae Sedis, a bacterial family that has been previously associated with decreased CDI risk. This study underscores the detrimental impact of antibiotics as well as other medications, particularly laxatives, on the intestinal microbiota and suggests that co-colonization with key bacterial taxa may prevent C. difficile overgrowth or the transition from asymptomatic C. difficile colonization to CDI.
- 14 March 2016
- Published by Springer Nature in Microbiome
- Vol. 4 (1) , 1-11
Open AccessBloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection
Clostridium difficile infection (CDI) is the leading infectious cause of nosocomial diarrhea. Hospitalized patients are at increased risk of developing CDI because they are exposed to C. difficile spores through contact with the hospital environment and often receive antibiotics and other medications that can disrupt the integrity of the indigenous intestinal microbiota and impair colonization resistance. Using whole metagenome shotgun sequencing, we examined the diversity and composition of the fecal microbiota in a prospective cohort study of 98 hospitalized patients. Four patients had asymptomatic C. difficile colonization, and four patients developed CDI. We observed dramatic shifts in the structure of the gut microbiota during hospitalization. In contrast to CDI cases, asymptomatic patients exhibited elevated relative abundance of potentially protective bacterial taxa in their gut at the onset of C. difficile colonization. Use of laxatives was associated with significant reductions in the relative abundance of Clostridium and Eubacterium; species within these genera have previously been shown to enhance resistance to CDI via the production of secondary bile acids. Cephalosporin and fluoroquinolone exposure decreased the frequency of Clostridiales Family XI Incertae Sedis, a bacterial family that has been previously associated with decreased CDI risk. This study underscores the detrimental impact of antibiotics as well as other medications, particularly laxatives, on the intestinal microbiota and suggests that co-colonization with key bacterial taxa may prevent C. difficile overgrowth or the transition from asymptomatic C. difficile colonization to CDI.
- Open Access
- 28 June 2013
- Published by Springer Nature in Microbiome
- Vol. 1 (1) , 18
Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection
Background: Antimicrobial use is thought to suppress the intestinal microbiota, thereby impairing colonization resistance and allowingClostridium difficileto infect the gut. Additional risk factors such as proton-pump inhibitors may also alter the intestinal microbiota and predispose patients toClostridium difficileinfection (CDI). This comparative metagenomic study investigates the relationship between epidemiologic exposures, intestinal bacterial populations and subsequent development of CDI in hospitalized patients. We performed a nested case–control study including 25 CDI cases and 25 matched controls. Fecal specimens collected prior to disease onset were evaluated by 16S rRNA gene amplification and pyrosequencing to determine the composition of the intestinal microbiota during the at-risk period.Results: The diversity of the intestinal microbiota was significantly reduced prior to an episode of CDI. Sequences corresponding to the phylum Bacteroidetes and to the families Bacteroidaceae and Clostridiales Incertae Sedis XI were depleted in CDI patients compared to controls, whereas sequences corresponding to the family Enterococcaceae were enriched. In multivariable analyses, cephalosporin and fluoroquinolone use, as well as a decrease in the abundance of Clostridiales Incertae Sedis XI were significantly and independently associated with CDI development.Conclusions: This study shows that a reduction in the abundance of a specific bacterial family - Clostridiales Incertae Sedis XI - is associated with risk of nosocomial CDI and may represent a target for novel strategies to prevent this life-threatening infection.
- 28 June 2013
- Published by Springer Nature in Microbiome
- Vol. 1 (1) , 18
Open AccessReductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection
Background: Antimicrobial use is thought to suppress the intestinal microbiota, thereby impairing colonization resistance and allowingClostridium difficileto infect the gut. Additional risk factors such as proton-pump inhibitors may also alter the intestinal microbiota and predispose patients toClostridium difficileinfection (CDI). This comparative metagenomic study investigates the relationship between epidemiologic exposures, intestinal bacterial populations and subsequent development of CDI in hospitalized patients. We performed a nested case–control study including 25 CDI cases and 25 matched controls. Fecal specimens collected prior to disease onset were evaluated by 16S rRNA gene amplification and pyrosequencing to determine the composition of the intestinal microbiota during the at-risk period.Results: The diversity of the intestinal microbiota was significantly reduced prior to an episode of CDI. Sequences corresponding to the phylum Bacteroidetes and to the families Bacteroidaceae and Clostridiales Incertae Sedis XI were depleted in CDI patients compared to controls, whereas sequences corresponding to the family Enterococcaceae were enriched. In multivariable analyses, cephalosporin and fluoroquinolone use, as well as a decrease in the abundance of Clostridiales Incertae Sedis XI were significantly and independently associated with CDI development.Conclusions: This study shows that a reduction in the abundance of a specific bacterial family - Clostridiales Incertae Sedis XI - is associated with risk of nosocomial CDI and may represent a target for novel strategies to prevent this life-threatening infection.